<DOC>
	<DOCNO>NCT01666912</DOCNO>
	<brief_summary>This prospective study compare two group 48 adolescent woman . The intervention group receive contraceptive implant postpartum , prior discharge hospital . The control group receive contraceptive implant usual 6 week postpartum clinic visit . During prenatal care , participant consent screened enrollment . After delivery , woman assess consented enrollment study . Women consent enrollment randomize . Women follow 3 month , 6 month , 9 month , 1 year contraceptive implant insertion . At follow , woman assess continuation satisfaction method contraception .</brief_summary>
	<brief_title>Postpartum Etonogestrel Implant Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Adolescents age 1424 attend prenatal care Greater 20 week estimate gestational age English Spanishspeaking Desire use contraceptive implant contraception postpartum Anticipated delivery healthy infant vaginally cesarean . Participants eligible participation contraindication contraceptive implant use , include current past history thrombosis thromboembolic disorder hepatic tumor ( benign malignant ) active liver disease undiagnosed abnormal genital bleed know suspected carcinoma breast ( personal history breast cancer ) hypersensitivity component contraceptive implant . Current use medication know induce hepatic enzyme , include limited : barbiturate , bosentan , carbamazepine , felbamate , griseofulvin , oxcarbazepine , phenytoin , rifampin , St. John 's wort , topiramate Characteristics would preclude involvement delivery : Birth stillborn infant . Maternal ICU admission delivery Maternal postpartum hemorrhage require blood transfusion Prolonged hospital stay ( &gt; 7 day ) postpartum Coagulopathy associate pregnancy Severe pregnancyinduced hypertension Fever &gt; 38 degree C postpartum Adolescent woman competent consent , secondary stress labor process , example severe pain sleep deprivation , offer enrolment trial</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>adolescence</keyword>
	<keyword>contraception</keyword>
	<keyword>postpartum</keyword>
	<keyword>rapid repeat pregnancy</keyword>
</DOC>